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Complementary medicine  
use in chronic disease:  
What is the evidence? 
The use of complementary and alternative medicine (CAM) is commonplace in 
people managing chronic disease. This RESEARCH ROUNDup highlights evidence for 
the medication-based CAM used to address chronic conditions considered national 
priority areas in Australia. Nevertheless, more high quality evidence on prevalence 
of use, concurrent use of other medications and profiles of CAM users particularly 
for specific conditions is required for consumers, clinicians (both CAM and non-
CAM), regulators, educators, researchers, policy-makers and funders. 
health priorities in Australia.10 What becomes apparent from this 
collection is that an enormous variety of CM is being trialled and 
there are ongoing challenges of rigour, quality and confounders. 
Critically this table only provides a summary of systematic 
reviews of Randomised Controlled Trials (RCTs); there are many 
other CAM therapies under investigation including Vitamin D and 
omega-3 polyunsaturated fatty acids.7 
In Australia the NHMRC have invested over $6 million of research 
funding to strengthen acceptance and integration of alternative 
therapies into the healthcare system.11 One such project is the 
CAM, Economics, Lifestyle and Other Therapeutic approaches 
(CAMELOT) for chronic conditions project, a three year (2008-
2011) series of studies designed to enhance understanding of the 
use of CAM in Australia.12 A multi-phase mixed methods 
interdisciplinary investigation has been undertaken, which 
explored why people under treatment for Diabetes Mellitus 
(DM) and cardiovascular disease (CVD) presented to and used 
CAM practitioners or therapies. Preliminary findings revealed 
that when discussing CAM therapies, there was confusion no 
matter how thoroughly it was defined or explained. For example, 
many potential participants indicated that they did not use any 
CAM, but went on to say that they took over-the-counter 
vitamins, minerals or herbal medicines, or they regularly had 
massage or saw a chiropractor, and so on.12 Phase 2 of the 
CAMELOT project collected survey data (N = 2 915) on CAM 
users. The profile of chronic disease patients using CAM was 
described as somewhat different to CAM users in the general 
population. Almost a third of the sample used CAM specifically 
for the treatment of CVD or DM. In contrast to suggestion that 
CAM is simply a ‘middle class commodity’ (p. 186)13, CAM users 
in the sample were often from lower socioeconomic status (SES) 
groups, with household incomes less than $50 000 p.a.12  
A similar pattern of CAM use and SES has been observed in older 
(>80 years) Australians with CVD, DM and Chronic Obstructive 
Pulmonary Disease.14 An Australia-wide survey asked about 
health service use and co-ordination in relation to chronic illness. 
Findings illustrated that a substantial percentage of consumers 
with chronic conditions (including DM, CVD or COPD) sought 
advice from CAM practitioners. In particular higher levels were 
observed for people with anxiety/depression (12%) renal 
conditions, chronic pain and osteoporosis.14  
Other reviews in Australia have targeted antioxidant use for 
cardiac patients15 and omega-3 fatty acids for people at ultra-
Chronic disease in Australia 
Chronic disease is defined as illness that is prolonged in duration, 
does not often resolve spontaneously, is rarely cured 
completely.1 Chronic diseases are currently responsible for more 
than 80 per cent of Australians’ burden of disease and injury.2 
Over 40 per cent of the adult population has one or more chronic 
conditions.2 Management of chronic conditions is predominantly 
a task for patients and their families/carers. A person with a 
chronic disease, such as diabetes, is provided with six hours of 
health professional contact in the Australian health system, 
leaving a total of 8 760 hours in which they need to manage on 
their own; monitoring blood sugar, administrating insulin and 
other medications and managing diet, physical activity and 
stress.3 
CAM use in chronic disease 
One of the central tenets of the Building a 21st Primary Health 
Care System Strategy4 is to improve self-management of chronic 
disease. Patients with chronic diseases increasingly look for 
healthcare outside of conventional health systems5 and often 
use complementary therapies alongside prescription 
medications.6 CAM can be taken to treat a disease, to treat 
symptoms or side-effects of treatment and for prevention. 
It is difficult to identify ‘best-evidence’ to inform decisions about 
CAM use, particularly as there is no universally agreed definition 
of CAM.7 Medicinal products containing herbs, vitamins, 
minerals, nutritional supplements, homoeopathic medicines and 
certain aromatherapy products are referred to as 
complementary medicines (CM). Other labels include 'alternative 
medicines', 'natural medicines' and 'holistic medicines'.8 
Additional terms sometimes used in discussing these healthcare 
practices include ‘natural medicine’, ‘non-conventional medicine’ 
and ‘holistic medicine’.9 CAM is commonly divided into two 
categories based on the modalities employed – medication-
based (eg. omega 3, green tea, st john/s wort, multivitamins) or 
procedure-based (eg. acupuncture, massage, naturopathy, 
osteopathy) manual therapies.  
Research Directions 
Table 1 provides a summary of systematic reviews undertaken in 
the last decade by the Cochrane Collaboration of CM use in the 
treatment of chronic conditions which are recognised as national 
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high risk of psychosis16,17 although RCTs are yet to be 
undertaken. Dementia has most recently been added as a 
chronic disease national priority area. As there currently exists 
no simple pharmacological option for treating Alzheimer’s 
disease, there has been substantial funding for multi-institutional 
research on the efficacy of natural medicines in improving 
memory, cognition, brain function and evaluation of nutritional 
supplements for treatment.7 
Summary 
CAM use for chronic disease management is a rapidly developing 
area and has the potential for significant benefits. CAM use is 
giving people with chronic disease additional choices for 
management of their conditions though there are concerns 
about understanding what is and is not a CAM and lack of 
disclosure to health professionals. Research for some 
interventions is in its infancy and there is a need to target future 
funding and resources not only into a rigorous evidence-base but 
also into developing an understanding about how CAM and 
conventional (biomedical) approaches can work together. 
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Table 1 Chronic disease priority areas and complementary medicine research—a summary of systematic reviews18 in the last 10 years 
Priority areas CM RCTs Findings 
Arthritis & 
Osteoporosis 
Herbal therapy (osteoarthritis) 5 Mixed, functional and pain improvement; less reliance on anti-inflammatory medication 
Asthma 
Homeopathy  6 
Inconclusive conflicting results due to lung function definition between studies; more RCTs and 
observational data required to assess differing methods of homeopathic prescribing 
Herbal interventions for adults and 
children 
27 
Mixed findings – some improved lung function; but findings hampered by variety of treatments 
assessed, poor reporting and lack of available data 
Cancer 
Mistletoe therapy during chemotherapy 21 
Some evidence of benefits on measures of quality of life during chemotherapy for breast cancer, 
results require replication 
Ganoderma lucidum 5 
Improved quality of life, minimal side-effects; enhanced tumor response and stimulated immunity; 
considered as an adjunct to conventional treatment; review will be updated every 2 years 
TCM for induction of remission (advanced/
late gastric cancer ) 
85 
Limited weak evidence for improved leukopenia and decreases in adverse events in the digestive 
system due to chemotherapy; no improvement in short-term remissions. Mixed findings due to 
different combinations of TCM, well-designed clinical trial required 
Cardiovascular 
Disease 
TCM for hypercholesterolemia 20 Promising results for Xuezhikang reducing total cholesterol 
TCM for acute ischaemic stroke 64 
Some improved neurologic outcomes, inadequate data to draw reliable conclusions; larger, 
rigorous trials required 
Shengmai for heart failure 9 
May be beneficial for improving function when paired with usual treatment;  high quality, long-
term data required 
Diabetes Type 2 diabetes and ayurvedic herbs 6 Some significant glucose-lowering effects with herbal mixtures 
Mental Health 
TCM  adjunct with antipsychotics for 
schizophrenia 
7 
Mixed; benefit in combination with antipsychotics, less constipation; since this review 45 more 
trials have been conducted yet to be reviewed 
Homeopathy for ADHD 4 
No significant  treatment effects on symptoms of inattention or hyperactivity or related outcomes; 
currently little evidence for efficacy 
Gluten and casein-free diets for autism 
spectrum disorder 
2 
High rates of CAM use in for children with autism; current evidence for efficacy of these diets is 
poor 
NB: Traditional Chinese Medicine (TCM) 
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